Tag Archives: Department of Health and Human Services

Regeneron Pharmaceuticals (Nasdaq: REGN) will supply an additional 1.25M treatment courses of an antibody cocktail composed of casirivimab and imdevimab to the U.S. government under a potential $2.63B agreement with the departments of Defense and Health and Human Services.

Moderna has received a six-month, $1.97B contract modification from the U.S. Army to manufacture 100M more doses of the company's messenger RNA vaccine against the novel coronavirus.

Pfizer has entered into an agreement with the departments of Health and Human Services and Defense to provide 100M more doses of the messenger RNA-based COVID-19 vaccine that the company developed with pharmaceutical firm BioNTech.

Merck (NYSE: MRK) has reached a $356M deal with the departments of Defense and Health and Human Services to further develop and seek regulatory approval MK-7110, the biopharmaceutical firm's investigational drug for hospitalized COVID-19 patients.

Thomas Scientific has secured a potential $105.8M indefinite-delivery/indefinite-quantity contract from the Defense Logistics Agency to provide nasopharyngeal swabs to five federal executive departments and the Indian Health Service.

The Department of Defense has issued eight contract actions worth $74.9M combined to help five companies preserve manufacturing and workforce capabilities that support U.S. military programs amid the COVID-19 pandemic.

Centerpoint has received a five-year, $116M contract to provide a range of cybersecurity support services to help the Department of Health and Human Services secure information technology infrastructure.

General Dynamics' (NYSE: GD) information technology business has won a potential five-year, $78M task order to help the Department of Health and Human Services manage the national child support program, G2Xchange Health reported Friday.

Eli Lilly and Co. (NYSE: LLY) has received a potential $375M contract from the departments of Defense and Health and Human Services to initially supply 300K doses of bamlanivimab, an investigational monoclonal antibody drug for COVID-19.

Palantir Technologies (NYSE: PLTR) is working on software for a new system that could help federal health officials track the production, administration and distribution of COVID-19 vaccines, The Wall Street Journal reported Thursday.